Background. Renal denervation reduces blood pressure (BP) and sympathetic drive in experimental animal models, but the effect of this intervention on sympathetic activity in patients with treatment-resistant hypertension is still unclear. Methods. In an incident series of 29 patients with treatmentresistant hypertension, we performed serial measurements (n ¼ 123) of muscle sympathetic nerve activity (MSNA, microneurography) and standardized BP measurements. Data were analysed by mixed linear modelling (MLM) and by regression analysis of time-integrated changes of both MSNA and synchronous, standardized (in-lab) BP measurements. Results. Bilateral renal denervation was accompanied by a marked reduction in MSNA (P ¼ 0.01 by MLM), which was parallelled by a reduction in systolic (from 175 6 14 to 156 6 16 mmHg) and, to a lesser extent, in diastolic (from 96 6 12 to 87 6 6 mmHg) BP over time. Neither systolic nor diastolic BP associated to a significant extent with corrected MSNA (MSNAC) in the MLM analysis (systolic BP versus MSNAC: b ¼ À0.08, P ¼ 0.08; diastolic BP versus MSNAC: b ¼ À0.007, P ¼ 0.75). However, the study of time-integrated changes in MSNA and BP showed a robust association between proportional changes in MSNA over time and simultaneous changes in systolic and diastolic BP (b ¼ 0.61, P < 0.001 and b ¼ 0.37 P < 0.05). Conclusions. Time-integrated changes in MSNAC and BP after bilateral renal denervation document a close link between the sympathetic activity and BP responses to this procedure. These findings further strengthen the relevance of the sympathetic nervous system both in the pathophysiology of resistant hypertension and in the BP-lowering effect of the procedure.
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I N T R O D U C T I O N
Resistant hypertension is a condition in which sympathetic activity attains the highest values [1] , similar to those detected in severe congestive heart failure [2] and higher than those seen in obesity [3] or in type 2 diabetes mellitus [4] . Even though the potentials of renal denervation for the treatment of resistant hypertension remain controversial, studies in experimental animal models have documented that renal denervation attenuates or abolishes disparate forms of experimentally induced hypertension and triggers a sustained reduction in sympathetic activity [5] .
Renal norepinephrine spillover is increased in primary and resistant hypertension, implicating renal nerves as a critical link between the increased central sympathetic drive and the alterations in renal function leading to hypertension [6] . Interestingly, renal sympathetic denervation shifts the renal pressure-natriuresis curve to the left, promoting urinary sodium excretion and lowering of blood pressure (BP) [7] . Seminal observations in a patient with uncontrolled hypertension showed that renal denervation is followed by a decline in BP and renal spillover of norepinephrine, accompanied by a sustained reduction in muscle sympathetic nerve activity (MSNA) [8] . A parallel decline in BP and MSNA emerged in another study in 35 patients with resistant hypertension [9] , but changes in MSNA and BP were unrelated in the same study and in three subsequent studies [1, 10, 11] . Of note, the authors of the last two studies [10, 11] remarked that reductions in sympathetic activity may be the exception rather than the rule after renal nerve ablation in patients with resistant hypertension. Thus it remains undefined whether renal denervation effectively reduces sympathetic activity in this condition and whether changes in sympathetic activity go along with the BP response to the same intervention. Recently, by applying a novel analytical approach to repeated microneurographic measurements of MSNA in 14 patients with resistant hypertension, we reported that sympathetic activity integrated over time undergoes a reduction after bilateral renal denervation and that this decline goes in parallel with the simultaneous integrated changes in plasma asymmetric dimethylarginine (ADMA) and with standardized BP measured in the lab [12] . Due to the small number of patients in this series, the hypothesis that parallel time-integrated observations of MSNA and BP after bilateral renal denervation reveal a strong link between the evolution of sympathetic activity and the BP response to this intervention required confirmation in a larger series. For this reason, we have now performed the analysis in a larger incident series of 29 patients with resistant hypertension who underwent a global number of 123 sequential measurements of MSNA over observation times ranging between 2 weeks and 9 months.
M A T E R I A L S A N D M E T H O D S

Study population
Patients were eligible for bilateral renal denervation if they had an office systolic BP !160 mmHg while on at least three antihypertensive drugs (including a diuretic) administered at full daily dosage and if they were !18 years of age. They did not display any known secondary cause of hypertension and had an estimated glomerular filtration rate (eGFR) determined by the Modification of Diet in Renal Disease formula !45 mL/min/1.73 m 2 . Patients with congestive heart failure, coronary and cardiovascular disease, atrial fibrillation or other major cardiac arrhythmias, diabetes mellitus, valvular heart disease, obstructive sleep apnea and those displaying poor adherence to antihypertensive drug treatment were also excluded from the study by proper examinations. Bilateral renal denervation was applied between 2013 and 2014 and the follow-up was extended to April 2015. Written informed consent was obtained from all patients.
The control group included 17 patients with treatmentresistant hypertension (defined as above) on long-term followup at our institution who did not undergo bilateral renal denervation because they refused the intervention or for logistic reasons. In these patients, measurements of MSNA were repeated at a 6-month time interval while antihypertensive drug treatment was maintained almost constant throughout.
The main patient characteristics (renal denervation and control group) are listed in Table 1 . The study was approved by the Ethics Committee of the IRCCS Multimedica, Sesto San Giovanni, Milan, Italy and conformed with the Declaration of Helsinki.
Measurements
BP was measured by a standard sphygmomanometer 30 min after the insertion of an intravenous cannula while patients were relaxed and accustomed to the experimental environment (standardized BP). Measurements also included (i) 24-h ambulatory BP monitoring (Spacelabs 90207; Spacelabs Healthcare, Issaquah, WA, USA) set to obtain automated BP and heart rate oscillometric readings at 15-and 20-min intervals during the daytime (7:00 AM-11:00 PM) and nighttime (11:00 PM-7:00AM) periods, respectively, and (ii) multi-unit recordings of efferent postganglionic MSNA via the microneurographic technique, which was performed in a semidark and quiet room at a constant temperature [13] . MSNA was quantified over each 30-min period and expressed as burst incidence corrected for heart rate (bursts/100 heartbeats). The 'normal' MSNA value in our laboratory measured in a series of 31 healthy subjects with an average age of 57.1 6 7 years was 45 bursts/100 heartbeats [95% confidence interval (CI) 42-50] [13] .
Protocol and data analysis
The study included up to five experimental sessions in a quiet semi-dark room kept at a constant temperature of [22] [23] [24] C. The first session was performed 5 days before bilateral renal denervation. The other sessions were scheduled for 15 days and 1, 3 and 6 months after the procedure. Patients abstaining from alcohol and coffee from at least 12 h were studied in the morning after a light breakfast, in the supine position. They were fitted an intravenous cannula and the measuring devices, except the microelectrode for MSNA recording. After 30 min, BP was measured three times with a sphygmomanometer (standardized BP) and a microelectrode was then inserted into the right or left peroneal nerve to obtain the MSNA. Bilateral renal denervation was carried out by employing a radiofrequency ablation catheter (Symplicity, Medtronic Ardian, Palo Alto, CA, USA) according to a protocol described elsewhere [1] . Data were analysed by a 
Statistical analysis
Data are expressed as mean 6 SD, median [interquartile range (IQR)] or as percent frequency, as appropriate. Sequential MSNA and systolic and diastolic BP measurements after renal denervation are described case by case in Supplementary data, Figures SA and SB. The global trend of MSNA and BP over time was analysed by two methods: by a mixed linear model, where the time after renal denervation was taken as the independent variable; and by testing the linear association between time-integrated changes in MSNA versus BP and heart rate after bilateral renal denervation. Time-integrated changes were calculated as the areas under the MSNA and BP curves by applying a standard method [14] . We then estimated the effect of bilateral renal denervation on MSNA as the difference between the expected area under the curve of MSNA assuming that renal denervation has no effect on sympathetic activity [i.e. a rectangular area formed by individual baseline MSNA values (short side, i.e. the height of the rectangle)] and the individual time of observation (long side, base of the rectangle; see Figure 1 ) and the actual area under the MSNA curve. We then expressed this difference as a percentage of the expected value, which provides an estimate of the change in MSNA following renal denervation. Identical calculations were carried out for BP and heart rate data. This technique was originally devised by C.Z., G.D. and G.T. to be applied for the analysis of the relationships between MSNA and a biomarker of endothelial function in a previous study [12] . All calculations were carried out by a standard statistical package (SPSS for Windows version 9.0.1; SPSS, Chicago, IL, USA).
R E S U L T S
The demographic, anthropometric and clinical characteristics of this incident series of 29 patients with treatment-resistant hypertension undergoing bilateral renal denervation are reported in Table 1 . Their average age was 61 years. All were treated with more than three antihypertensive drugs, including a diuretic, all at full daily dosage. Their 'standardized', in-lab BP was 175 6 14/96 6 11 mmHg, while their 24-h ambulatory BP was 156 6 14/88 6 8 mmHg. In all, 16 patients were overweight All displayed left ventricular hypertrophy at the echocardiographic examination. Antihypertensive drugs taken by these patients are detailed in Table 1 . These drugs were continued throughout the whole follow-up without any change or with very minor modifications.
The median MSNA was 61 bursts/100 heartbeats; this value being above the upper limit of the 95% CI (50 bursts/100 heartbeats) of the normal range in all but three patients. Bilateral renal denervation was uneventfully performed in all cases and six was the average number of ablations per kidney per patient. No long-term complications were recorded in this series. Antihypertensive therapy remained the same after denervation and no patient had cardiovascular events during follow-up. The individual time course of systolic BP, diastolic BP and MSNA at baseline (pre-sympathetic denervation) and at various time points during follow-up are shown in Supplementary data, Figures SA and SB. Overall, bilateral renal denervation markedly reduced MSNA (from 67.5 6 13.1 to 51.3 6 15.5 burst/100 heartbeats; P ¼ 0.01 by mixed modelling) and on average induced a 21 mmHg decrease in standardized, in-lab systolic BP (from 175 6 14 to 156 6 16 mmHg) and a 9 mmHg decrease in diastolic BP (from 96 6 12 to 87 6 6 mmHg) (Figure 2 ). However, neither systolic nor diastolic BP associated to a significant extent with MSNAC in the mixed linear modeling analysis (systolic BP versus MSNAC: b ¼À0. 08, P ¼ 0.08; diastolic BP versus MSNAC: b ¼ À0.007, P ¼ 0. 75). Heart rate values remained almost unchanged throughout (from 67 6 12 to 66 6 12 beats/min).
Time-integrated changes in MSNA and hemodynamic variables
Time-integrated changes in MSNA after bilateral renal denervation showed a wide range between patients, from À40.6% to þ10.2% (average À15.5%), and the observed time-integrated MSNA values were significantly less (P 0.001) than the corresponding expected values (the rationale of this analysis is provided in Materials and methods and in Figure 1 ). Similar to MSNA, time-integrated standardized systolic [À8.3% (range FIGURE 1: Calculation of the difference between the expected area under the curve of study variables (MSNAC in the example). We calculated the difference between the expected area under the curve of MSNAC assuming that renal denervation has no effect on this variable [i.e. a rectangular area formed by individual baseline value (short side) and the individual time of observation (long side)] and the actual area under the MSNAC curve and then expressed this difference as a percentage of the expected value.
S y m p a t h e t i c a c t i v i t y a n d B P a f t e r r e n a 3)] and diastolic BP [À8.1% (range À24.7% to 17.6%)] were lower than those expected by assuming no effect of renal denervation (for both, P < 0.001). This was not the case for heart rate [À1.01% (range À13.4% to þ7.9), P ¼ 0.14]. Remarkably, time-integrated changes in MSNA went along with simultaneous changes in time-integrated standardized BP measurements (systolic, R ¼ 0.61, P < 0.001; diastolic, R ¼ 0.37, P ¼ 0.046) (Figure 3) , while no significant relationship between MSNAC and heart rate (R ¼ 0.20, P ¼ 0.13) or 24-h systolic (R ¼ À0.03, P ¼ 0.90) or diastolic BPs (R ¼À0.17, P ¼ 0.40) was detected.
Control group
In patients with treatment-resistant hypertension maintained on unchanged antihypertensive drug treatment, no modification in MSNA values or in systolic and diastolic BPs was found at the 6-month follow-up visit (Figure 4 ).
D I S C U S S I O N
In this study based on repeated MSNA and BP measurements after bilateral renal denervation, baseline MSNA assessed in the peroneal nerve was substantially elevated before renal denervation and time-integrated changes in sympathetic activity after renal denervation were closely related to synchronous BP changes. These findings are in keeping with the hypothesis that sympathetic overactivity is a hallmark of the resistant hypertensive state.
Resistant hypertension represents a high cardiovascular risk condition [15] and sympathetic overactivity is regarded as a major factor underlying the excessive cardiovascular morbidity of the disease [16] . Sympathetic activity has been reported to be remarkably high in resistant hypertension [1, 17] and renal denervation was specifically conceived as an intervention targeting this alteration to restore BP control [17] . Careful studies under rigorously controlled experimental conditions in the first patient with resistant hypertension who underwent bilateral renal denervation showed a marked increase in norepinephrine spillover in both kidneys and this decreased by 48% (left kidney) and 75% (right kidney) after the intervention [8] . In this patient, BP progressively attained normal values over the following year while MSNA gradually declined over the same time interval [8] .
After this seminal study, only four studies have investigated the relationship between directly measured sympathetic activity and BP after renal denervation. The largest among these studies (35 patients) confirmed a progressive parallel decline in BP and MSNA, but conventional regression analysis failed to show a meaningful relationship between these two variables after renal denervation [9] . On the other hand, in a study by Brinkmann et al. [10] in 12 patients, renal denervation left unmodified both BP and MSNA after an average observation period of 5 months. Likewise, MSNA remained unchanged in a series of five patients restudied 6 months after renal denervation [11] . In a longitudinal study in 15 patients contemplating repeated MSNA recordings, we found that bilateral renal denervation has no short-term effects on MSNA but is followed by a clear-cut, late decline in this parameter 3 months after denervation, at a time when a meaningful reduction in BP had already occurred [1] . Collectively, these observations failed to document a meaningful relationship between the evolution of sympathetic activity and BP after renal denervation, even though in our study, both at 3 and 6 months, we found a close relationship between changes in baroreflex control of MSNA and MSNA changes post-denervation [1] .
The lack of a relationship between MSNA and BP in these studies may depend on various factors, including the small sample size, the inadequate reflection of the true underlying sympathetic activity by multifibre MSNA and a role of neural pathways other than the sympathetic ones [18] . Single-fibre MSNA is a methodology more sensitive than multi-unit MSNA (the technique adopted in this study) for capturing postdenervation changes in sympathetic activity, and single-fibre MSNA decreases substantially after catheter-based renal nerve ablation while multi-unit MSNA undergoes just small changes [19] . However, perhaps due to differences in design and statistical analysis, no relationship was found between single-fibre MSNA and BP in this study [19] . Along with the concept that the sympathetic system is of paramount relevance in long-term BP control in humans [20] , it is also possible that the effect on BP by the reduced exposure to high sympathetic activity after denervation is a long-term process that gradually builds up over time. If so, the relationship between sympathetic activity and BP, rather than by conventional regression analysis applied to single time points, may be better captured by time-integrated measurements of MSNA and BP. The use of summary measures like the calculation of the area under the curve to analyse cumulative exposures is a useful and simple tool in medical research [14] that has been applied to estimate the cumulative, long-term exposure to risk factors, including hypertension [21] , hyperlipidaemia [22] , hyperglycaemia [23] . Such an approach provides better estimates of the health hazards of exposure to risk factors as compared with single measurements of the same factors [20] . Confirming a pilot analysis in a smaller series of patients looking at the link between sympathetic activity and ADMA [12] , in the present study we found that after bilateral renal denervation, timeintegrated changes in sympathetic activity and in standardized (in-lab) BP measurements-but not individual data of the same variable-are strongly related. Standardized BP measurements in the laboratory synchronous with MSNA measurements more directly reflect the influence of the sympathetic neural influences on the cardiovascular system, while 24-h ambulatory BP measurements are influenced to an important extent by the life environment and are therefore less suitable for the study of sympathetic activity on BP control, which may explain the lack of relationships between this parameter and time-integrated changes in 24-h ambulatory BP.
Overall, the present study based on 123 sequential measurements of MSNA in 29 patients supports the contention that a reduction in sympathetic activity has a key role for the achievement of BP control in hypertensive patients resistant to treatment. Our analyses have pathophysiological, rather than clinical, implications and go along with recent observations showing a very strong link between the BP response to renal nerve stimulation and the short-and long-term postprocedural BP response to renal denervation [24] , a response that is inherently dependent on mitigation of the very high sympathetic activity of this condition.
In conclusion, sequential measurements of sympathetic activity and simultaneous standardized BP measurements analysed by a statistical approach computing time-integrated changes in these variables after renal denervation show a strong link between the evolution of sympathetic activity and BP after this procedure. These findings further highlight the relevance of the sympathetic system in resistant hypertension.
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